期刊
EXPERT REVIEW OF PROTEOMICS
卷 11, 期 4, 页码 449-463出版社
TAYLOR & FRANCIS LTD
DOI: 10.1586/14789450.2014.905743
关键词
biomarker; colorectal cancer; plasma; serum; shotgun proteomics; targeted proteomics
资金
- Institute for Promotion of Innovation through Science and Technology in Flanders (IWT) [IM110568]
- Emmanuel Van der Schueren grant of Vlaamse Liga tegen kanker (VLK)
- Flemish Institute for Technological Research (VITO)
- Industrial Research Fund (KU Leuven)
Globally, colorectal cancer (CRC) is the third most common malignant neoplasm. However, highly sensitive, specific, noninvasive tests that allow CRC diagnosis at an early stage are still needed. As circulatory blood reflects the physiological status of an individual and/or the disease status for several disorders, efforts have been undertaken to identify candidate diagnostic CRC markers in plasma and serum. In this review, the challenges, bottlenecks and promising properties of mass spectrometry (MS)-based proteomics in blood are discussed. More specifically, important aspects in clinical design, sample retrieval, sample preparation, and MS analysis are presented. The recent developments in targeted MS approaches in plasma or serum are highlighted as well.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据